Abstract

There are increasing pieces of evidence suggesting that the recurrence of cancer may result from a small subpopulation of cancer stem cells, which are resistant to the conventional chemotherapy and radiotherapy. We investigated the effects of Chinese herbal mixture Tien-Hsien Liquid (THL) on the cancer stem-like side population (SP) cells isolated from human hepatoma cells. After sorting and subsequent culture, the SP cells from Huh7 hepatoma cells appear to have higher clonogenicity and mRNA expressions of stemness genes such as SMO, ABCG2, CD133, β-catenin, and Oct-4 than those of non-SP cells. At dose of 2 mg/mL, THL reduced the proportion of SP cells in HepG2, Hep3B, and Huh7 cells from 1.33% to 0.49%, 1.55% to 0.43%, and 1.69% to 0.27%, respectively. The viability and colony formation of Huh7 SP cells were effectively suppressed by THL dose-dependently, accompanied with the inhibition of stemness genes, e.g., ABCG2, CD133, and SMO. The tumorigenicity of THL-treated Huh7 SP cells in NOD/SCID mice was also diminished. Moreover, combination with THL could synergize the effect of doxorubicin against Huh7 SP cells. Our data indicate that THL may act as a cancer stem cell targeting therapeutics and be regarded as complementary and integrative medicine in the treatment of hepatoma.

Highlights

  • In recent years, there has been increasing evidence supporting the notion that tumors are organized in hierarchical heterogeneous cell populations [1]

  • We investigated the effects of Chinese herbal mixture Tien-Hsien Liquid (THL) on the cancer stem-like side population (SP) cells isolated from human hepatoma cells

  • Combination with THL could synergize the effect of doxorubicin against Huh7 SP cells

Read more

Summary

Introduction

There has been increasing evidence supporting the notion that tumors are organized in hierarchical heterogeneous cell populations [1]. Recent researches show that CSCs are much more resistant to conventional cancer therapy than the other bulk cancer cells. One common method to isolate the CSCs for therapeutics screening is the side population (SP) technique, which is originally used to detect the hematopoietic stem cells in bone marrow. This technique detects the so-called SP cells by dual-wavelength flow cytometry on the basis of the ability of these cells to efflux the fluorescent DNA-binding dye Hoechst 33342 [3]. The SP phenotype is characterized by breast-cancer-resistant protein-1 (BCRP1 or ABCG2), one of Evidence-Based Complementary and Alternative Medicine

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call